BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, June 19, 2026
Home » Authors » Peter O'Donnell

Articles by Peter O'Donnell

Pharma 'Blocked Innovation,' EU Authorities Charge

Dec. 3, 2008
By Peter O'Donnell

Biofirms See Rare Diseases Initiative as Lever on Pricing

Nov. 19, 2008
By Peter O'Donnell

Europe's Biofirms Alarmed at Animal Testing Controls

Nov. 12, 2008
By Peter O'Donnell

Europe Stumbles over New Pharma Rules

Nov. 5, 2008
By Peter O'Donnell

Easier Rules Advanced for Product Variations

Oct. 29, 2008
By Peter O'Donnell

Firms Say Advanced Therapies Still Lack Clear EU Definition

Oct. 22, 2008
By Peter O'Donnell

Biopharma Group Applauds Results of High-Level Forum

Oct. 8, 2008
By Peter O'Donnell

European Health Lobbies Look for 2009 Policy Opportunities

Sep. 24, 2008
By Peter O'Donnell

Poland and EU Head for New GM Law Clash

Sep. 10, 2008
By Peter O'Donnell

European Research Funding Caught in Ethical Controls

Sep. 3, 2008
By Peter O'Donnell
BRUSSELS, Belgium - European Union generosity in supporting biotech research is being qualified by persistent concessions to the diversity of ethical views across the EU's 27 member states. (BioWorld International)
Read More
Previous 1 2 … 6 7 8 9 10 11 12 13 14 … 68 69 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 18, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 16, 2026
  • Brain with puzzle piece removed

    Gene replacement rescues autism-related phenotypes in mice

    BioWorld Science
    Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
  • Red blood cells, DNA

    For clonal hematopoiesis, epigenetics can be in driver’s seat

    BioWorld Science
    Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
  • Illustration of amyloid plaques in Alzheimer's disease

    Elixiron’s enrupatinib shows upbeat interim phase II AD results

    BioWorld
    Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing